Lhasa Limited shared knowledge shared progress


Jump to results
Publication Type
Publication Year
Related Products
New search
Publications search results
Improvements to in silico skin sensitisation predictions through privacy-preserving data sharingDerek Nexus
What Makes a Potent Nitrosamine? Statistical Validation of Expert-Derived Structure–Activity RelationshipsDerek NexusVitic
Use of the bacterial reverse mutation assay to predict carcinogenicity of N-nitrosaminesComplex NitrosaminesDerek NexusSarah Nexus
How to resolve inconclusive predictions from defined approaches for skin sensitisation in OECD Guideline No. 497Derek Nexus
Validation of Nexus v.2.5.2 for Ames Mutagenicitypdf fileDerek NexusSarah Nexus
Lhasa Limited's Skin Sensitisation Assessment Portfolio Infographicpdf fileDerek NexusVitic
Updating the Dermal Sensitisation Thresholds using an expanded dataset and an in silico expert systemDerek Nexus
An Evaluation of the Occupational Health Hazards of Peptide CouplersDerek Nexus
Assessment of the dermal sensitisation potency of extractables and leachables using existing data and in silico methodspdf fileViticDerek Nexus
Updated Dermal Sensitisation Thresholds derived using an in silico expert system and an expanded Local Lymph Node Assay datasetpdf fileDerek Nexus
Validation statistics for negative predictions in Derek Nexus 2022 1.0pdf fileDerek Nexus
Chapter 3: Control Strategies for Mutagenic ImpuritiesMirabilisDerek NexusSarah Nexus
Chapter 9: Mutagenic Impurities – Assessment of Fate and Control OptionsDerek NexusSarah NexusMirabilis
Chapter 17: Use of Lhasa Limited Products for the In Silico Prediction of Drug ToxicityDerek NexusSarah NexusMirabilisZeneth
Chapter 7: Compound- and Class-Specific Limits for Common Impurities in PharmaceuticalsDerek NexusSarah NexusLhasa Carcinogenicity DatabaseMirabilisAI/PDE Data Sharing Project
Developing structure-activity relationships for N-nitrosamine activityDerek Nexus
How carboxylic and sulfonic acid halides are represented within Derek Nexus and Sarah Nexuspdf fileDerek NexusSarah Nexus
In Silico Prediction of Genotoxicity Current Applications and Future Perspectivespdf fileDerek NexusSarah Nexus
QSAR 2021 Addressing the global challenge of N-nitrosamine impurity assessmentpdf fileDerek NexusMirabilisSarah NexusVitic
Predicting N-Nitrosamine Activity from SARpdf fileDerek NexusSarah NexusLhasa Carcinogenicity DatabaseNitrites in Excipients
Development of an Adverse Outcome Pathway Network to Support an Integrated Approach to Testing and Assessment of Carcinogenic Risk - SOT 2021 Presentation Slidespdf fileKaptisDerek Nexus
Nexus ICH M7 Expert Review Support Functionality (an infographic)pdf fileDerek NexusSarah Nexus
Management of pharmaceutical ICH M7 (Q)SAR predictions – The impact of model updatesDerek NexusSarah NexusVitic
The importance of expert review to clarify ambiguous situations for (Q)SAR predictions under ICH M7Derek NexusSarah Nexus
Integrating Knowledge Of Carcinogenicity Adverse Outcome Pathways (AOPs) With Experimental Data_EMGS Data Challenge 2020pdf fileKaptisDerek NexusVitic

© 2023 Lhasa Limited | Registered office: Granary Wharf House, 2 Canal Wharf, Leeds, LS11 5PS, UK Tel: +44 (0)113 394 6020
VAT number 396 8737 77 | Lhasa Limited is registered as a charity (290866)| Company Registration Number 01765239 (England and Wales).